Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,150.00
+170.00 (2.84%)
Last updated: Apr 1, 2025

Pharos iBio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
78,06498,001191,588---
Upgrade
Market Cap Growth
-48.85%-48.85%----
Upgrade
Enterprise Value
62,52080,945164,210---
Upgrade
Last Close Price
6030.007570.0014830.00---
Upgrade
PB Ratio
4.195.276.76---
Upgrade
P/TBV Ratio
5.395.396.79---
Upgrade
Debt / Equity Ratio
0.010.010.010.02-0.04-0.68
Upgrade
Asset Turnover
---0.010.000.02
Upgrade
Quick Ratio
16.2516.2521.1516.060.560.86
Upgrade
Current Ratio
16.7016.7021.5716.530.570.88
Upgrade
Return on Equity (ROE)
-44.97%-44.97%-38.50%-1825.61%--
Upgrade
Return on Assets (ROA)
-31.94%-31.94%-26.12%-28.73%-23.78%-32.64%
Upgrade
Return on Capital (ROIC)
-33.24%-33.24%-27.09%-469.65%--
Upgrade
Earnings Yield
-13.53%-10.78%-4.62%---
Upgrade
FCF Yield
-12.82%-10.21%-4.31%---
Upgrade
Buyback Yield / Dilution
-6.81%-6.81%-36.26%-53.03%-2.65%-1.86%
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.